Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Eicosapentaenoic Acid and Clopidogrel

Research Papers that Mention the Interaction

In conclusion, EPA treatment at a sufficient dose suppressed platelet aggregation and showed possible add-on effects in patients with clopidogrel hyporesponsiveness.
International heart journal  •  2017  |  View Paper
The EPA-AA ratio (P = .001) and ankle–brachial index (ABI: P < .001) in group A were significantly lower than those in group B. Univariate and multivariate analyses demonstrated that EPA-AA , ABI, and prescription of clopidogrel had significant correlation with PAD.
Angiology  •  2013  |  View Paper
The lower baseline %PA may explain why the pediatric clopidogrel dose providing 30–50% IPA (0.20 mg/kg/day) is lower than a simple weight-based extrapolation of the adult dose (75 mg/day) providing similar inhibition.
Platelets  •  2012  |  View Paper
An additional 300 mg dose of clopidogrel improves both IPA and P2Y(12) receptor occupancy mostly in the subset of 'low' responders.
The additional 300 mg dose of clopidogrel on top of 75 mg chronic treatment increased IPA and P2Y(12) receptor occupancy in all groups, but relatively more in low responders.
Thrombosis and haemostasis  •  2009  |  View Paper